Parker Waichman LLP

Injured InFuse Users Working Toward Their Day in Court

Hundreds of people allegedly injured following procedures involving Medtronic’s InFuse are utilizing a different legal approach. The arguments planned include that the U.S. Food and Drug Administration (FDA) issued a warning in 2008 to physicians concerning “life-threatening complications” from unapproved applications of InFuse, according to the Star Tribune. InFuse, is a synthetic, or genetically engineered, […]

medtronic_infuse_victimsHundreds of people allegedly injured following procedures involving Medtronic’s InFuse are utilizing a different legal approach.

The arguments planned include that the U.S. Food and Drug Administration (FDA) issued a warning in 2008 to physicians concerning “life-threatening complications” from unapproved applications of InFuse, according to the Star Tribune. InFuse, is a synthetic, or genetically engineered, recombinant human Bone Morphogenetic Protein (rhBMP-2) approved by the FDA in 2002 for specific uses. Meant to stimulate spine growth in patients suffering from lower spinal degenerative disease, InFuse is approved for use in one type of spinal surgery and some dental procedures. InFuse has never been approved for use on the upper, or cervical spine, where it is now widely used in off-label procedures.

The way in which Medtronic marketed InFuse has been the subject of fierce controversy. There are concerns over how Medtronic-funded research was conducted for InFuse and Medtronic has also been accused of touting InFuse off label and of downplaying the device’s risks while overstating its benefits. Medtronic and InFuse have been the subject of a Senate probe, in addition to the FDA warning, and the subject of two recently completed independent studies. The studies reveal that InFuse is not any better than traditional, patient-harvested bone grafting and is also associated with serious adverse events, including increased cancer risks.

Senate investigators charged that Medtronic intentionally influenced studies to downplay adverse reaction data associated with InFuse, while touting its off label uses. The U.S. Senate Finance Committee found issues with most of the initial Medtronic-supported InFuse research that was used to promote the bone graft product. Also, a special 2011 publication of The Spine Journal was devoted to reports that critiqued InFuse research conducted by surgeons who received millions of dollars from Medtronic and accused Medtronic of not reporting serious complications associated with InFuse.

Because of a legal concept known as “pre-emption,” InFuse has never been the focus of a personal injury trial. This is because federal law takes precedence over state law, the Star Tribune explained. In fact, the Supreme Court extended pre-emption so that consumers are unable to bring about lawsuits for damages caused by medical devices that received pre-market FDA approval, which includes InFuse. The new lawsuits are seeking a way to circumvent pre-emption and accuse Medtronic of illegally touting InFuse for purposes not approved by the agency, according to the Star Tribune.

Although physicians are free to use devices off-label as they see fit, device makers are banned from marketing devices for purposes not approved by the FDA. Significantly, Infuse is used in off-label procedures in massive 85 percent of all cases. “If you are injured by a product that was used in a way not approved by the FDA,” who is responsible? asks Jennifer Fuson, spokeswoman for the American Association for Justice, the Star Tribune reported. “Promotional materials are unlawful if they promote an unapproved use for the product; contain claims relating to the dosing, safety or effectiveness of the product that are inconsistent with the approved labeling; or if they lack a fair and balanced presentation of information, i.e., of benefits and risks,” the FDA says.

At least one attorney points out that significant off-label InFuse use points to some type of promotion occurring, according to the Star Tribune. In excess of eight out of every 10 cases in which InFuse is used, the device is used in ways that are not approved by the FDA. The figures are significant.

Despite all this, Medtronic continues to market InFuse and has not implemented a recall. Most patients and physicians are unaware of the notorious history connected to Medtronic’s InFuse and that traditional bone grafting—in which bone is patient harvested—is a viable option.

Meanwhile, InFuse has been associated with an array of adverse reactions, including bone dissolution; Cauda Equina Syndrome (“Horse Tail” Syndrome); compressed airways; cysts; difficulty swallowing, breathing, and/or speaking; gastrointestinal problems; excessive swelling in the neck; increased cancer risks; infections; male infertility, sterility; nerve injuries and nerve damage; pain, chronic pain; retrograde ejaculation; swelling of the neck resulting in injury or death; uncontrolled bone growth; and worsened back and leg pain.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Gary C. January 2022 I was diagnosed with Prostate Cancer in 2017. Which was caused by breathing in the toxic air from the WTC attack. I reached out to Parker Waichman for guidance in dealing with Victims Compensation Fund. My paralegal is Ms. Nicole Copertino.. There isn't enough words to describe her knowledge, professionalism and all the help she has provided during these stressful times. Without any hesitation I would recommend Parker Waichman to family, friends and business associates. Kudos to Ms. Copertino and her team at Parker Waichman.
Gary Chastven
2 years ago
5 Star Reviews 150
Positive: Professionalism , Quality , Responsiveness , Value Gina Vita is a very courteous, kind, informative and helpful. An asset to your organization
Steven Donohue
2 years ago
5 Star Reviews 150
I am very grateful for the extraordinary service I received at Parker Waichman. Thanks to Melissa and Jorge for all their help
Blas Diaz
a year ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038